Pawel Baranczewski

Head of Unit: ADME of Therapeutics, Uppsala University

pawel.baranczewski@scilifelab.se

0707467894

Keywords

ADME, bioanalysis, biotransformation, DDIs, mass spectrometry (MS), PBPK simulations, pharmacokinetics (PK), PKPD modeling

Key Publications

AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine–associated receptor 1

Science Advances, 2024

Transfer of cetirizine/levocetirizine into human breast milk and estimation of drug exposure to infants through breastfeeding ‐ a human lactation study from the ConcePTION project

Basic & Clinical Pharmacology & Toxicology, 2023

Simple and rapid quantification of cetirizine, venlafaxine, and O-desmethylvenlafaxine in human breast milk, and metformin in human milk and plasma with UHPLC-MS/MS

Journal of Chromatography B, 2022

SciLifeLab / Contact / Pawel Baranczewski

Pawel Baranczewski

Associate Professor (Docent) in preclinical drug development. 14 years of industrial experience within the area of drug discovery and development. Particular expertise in ADME, pharmacokinetics (PK) and pharmaceutical profiling of drug compounds. Demonstrated ability to set up and run highly functioning laboratories. Hands-on experience with in vitro ADME, in vivo PK and pharmaceutical profiling assays, PBPK simulations and PKPD modelling as well as with LC-MS/MS technique. More than a decade of experience within leadership and coordination of interdisciplinary teams.

Group Members

Anders Eneroth
Aljona Saleh
Ivailo Simoff
Richard Svensson
Jimmy Ytterberg

Last updated: 2025-01-17

Content Responsible: David Gotthold(david.gotthold@scilifelab.se)

Help Us Improve!

We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.

Take the survey

Help Us Improve!

Take the survey